Shares of Kailera Therapeutics fell 10% on Tuesday, a decline triggered by late-stage trial results showing that its oral ...
Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
Get all the latest news and updates on Serum Institute only on News18.com. Read Politics news, current affairs and news headlines online on Serum Institute News today.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results